Riptide Bioscience, Inc. is a privately held biopharmaceutical company developing novel peptide therapeutics for the treatment of cancer, inflammatory diseases, and bacterial infections. Riptide's peptides are based on key structures of naturally occurring host-defense peptides, but engineered to have many times the efficacy of the natural compounds. The company has shown the potential of its novel peptides to fight infection in acute disease, to modulate the activity of tumor-associated macrophages to fight cancer, and to moderate harmful inflammation in chronic conditions like scleroderma and other fibrotic diseases. Riptide is now preparing to initiate human clinical testing of its peptides, initially as a potential treatment for scleroderma.
| Website | http://www.riptidebio.com |
| Revenue | $5 million |
| Employees | View employees |
| Address | 941 Railroad Ave, Vallejo, California 94592, US |
| Phone | +1 650-369-4100 |
| Fax | (650) 227-2288 |
| Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare |
| Competitors | ZymoGenetics, BASF, Ecolab, DuPont, Catalent Pharma Solutions, Geno, Solazyme , Inc., AquaBounty, Ceres, Inc., Verdezyne +42 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular Riptide Bioscience Inc employee's phone or email?
The Riptide Bioscience Inc annual revenue was $5 million in 2026.
Riptide Bioscience Inc is based in Vallejo, California.
The NAICS codes for Riptide Bioscience Inc are [5417, 541714, 54, 541, 54171].
The SIC codes for Riptide Bioscience Inc are [87, 873].